Abbott to establish its innovation centre in Mumbai
Global drug maker Abbott has announced to set up an innovation and development (I&D) centre in Mumbai. The centre aims […]
Allergan to Buy Kythera Biopharmaceuticals for US$ 2.1 Billion
Allergan Plc, a botox-maker, said it has planned to buy Kythera Biopharmaceuticals Inc in a cash-and-stock deal valued at about […]
Sanofi to produce synthetic antimilarial drugs
French drug maker Sanofi has announced the launch of a new commercial-scale manufacturing process to develop tons of artemisinin, the […]
USFDA Withdrwas Sales Ban as Indian Pharma Companies Take Corrective Measures
A new recommendation has come in for the Indian drug companies. Most Indian drug companies that were penalised for violating […]
New licensing norms soon for Pharma Companies
The industry department is about to finalise the terms under which the government can order the manufacture of drugs without seeking the permission of the patent holder by the end of this month.
Biocon in drug marketing deal with Pfizer
The world’s top drug maker Pfizer said that it has entered into a deal to sell drug maker Biocon Ltd’s biosimilar versions of diabetes treatment insulin.
Now a website to offer health advice even from marketers
A website, Sharecare.com, is all set to provide platform to provide consumers with what they want to know on health and wellness subjects, reports New York Times.
Vaccine plant in Singapore for pneumonia by GSK
On Tuesday, drug maker GlaxoSmithKline (GSK), established a US $600 million plant in Singapore that is stated to begin producing anti-pneumonia vaccine in 2011.
GE Healthcare and Merck to partner
GE Healthcare has signed an agreement with drug maker Merck & Co, to provide lung imaging technology to assist in respiratory drug development, says CNN Money.
Wockhardt hiving off R&D business
Drug maker Wockhardt has announced it will spin off its R&D business and list the new company on stock exchange on January 1, 2009. The company thus has followed similar moves by other pharma companies, who have hived off their research and development units.
NEWS REVIEW – BUSINESS
[This article was published in the November 2007 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
News Review
Wockhardt buys Morton Grove for $38 mn
Indian drug maker Wockhardt recently acquired US-based speciality drugs company Morton Grove Pharmaceuticals, which has annual sales of $52 million.
